GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Standard BioTools Inc (NAS:LAB) » Definitions » E10

LAB (Standard BioTools) E10 : $-1.75 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Standard BioTools E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Standard BioTools's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.75 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was -3.50% per year. During the past 5 years, the average E10 Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Standard BioTools was 31.00% per year. The lowest was -4.40% per year. And the median was 3.10% per year.

As of today (2025-03-14), Standard BioTools's current stock price is $1.14. Standard BioTools's E10 for the quarter that ended in Dec. 2024 was $-1.75. Standard BioTools's Shiller PE Ratio of today is .


Standard BioTools E10 Historical Data

The historical data trend for Standard BioTools's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools E10 Chart

Standard BioTools Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.66 -1.58 -1.81 -1.89 -1.75

Standard BioTools Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.89 -1.87 -1.84 -1.79 -1.75

Competitive Comparison of Standard BioTools's E10

For the Medical Devices subindustry, Standard BioTools's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Standard BioTools's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Shiller PE Ratio falls into.



Standard BioTools E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Standard BioTools's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.09/133.1571*133.1571
=-0.090

Current CPI (Dec. 2024) = 133.1571.

Standard BioTools Quarterly Data

per share eps CPI Adj_EPS
201503 -0.560 99.621 -0.749
201506 -0.530 100.684 -0.701
201509 -0.320 100.392 -0.424
201512 -0.450 99.792 -0.600
201603 -0.690 100.470 -0.914
201606 -0.640 101.688 -0.838
201609 -0.680 101.861 -0.889
201612 -0.610 101.863 -0.797
201703 -0.590 102.862 -0.764
201706 -0.580 103.349 -0.747
201709 -0.460 104.136 -0.588
201712 -0.270 104.011 -0.346
201803 -0.340 105.290 -0.430
201806 -0.420 106.317 -0.526
201809 -0.380 106.507 -0.475
201812 -0.360 105.998 -0.452
201903 -0.440 107.251 -0.546
201906 -0.200 108.070 -0.246
201909 -0.190 108.329 -0.234
201912 -0.182 108.420 -0.224
202003 -0.230 108.902 -0.281
202006 -0.180 108.767 -0.220
202009 -0.080 109.815 -0.097
202012 -0.240 109.897 -0.291
202103 -0.250 111.754 -0.298
202106 -0.230 114.631 -0.267
202109 -0.180 115.734 -0.207
202112 -0.120 117.630 -0.136
202203 -0.990 121.301 -1.087
202206 -0.820 125.017 -0.873
202209 -0.370 125.227 -0.393
202212 -0.260 125.222 -0.276
202303 -0.210 127.348 -0.220
202306 -0.220 128.729 -0.228
202309 -0.270 129.860 -0.277
202312 -0.250 129.419 -0.257
202403 -0.270 131.776 -0.273
202406 -0.120 132.554 -0.121
202409 -0.070 133.029 -0.070
202412 -0.090 133.157 -0.090

Add all the adjusted EPS together and divide 10 will get our e10.


Standard BioTools  (NAS:LAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Standard BioTools E10 Related Terms

Thank you for viewing the detailed overview of Standard BioTools's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Executives
Casdin Partners Master Fund, L.p. director, 10 percent owner WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001
Martin D Madaus director 290 CONCORD ROAD, BILLERICA MA 01821
Jeffrey G. Black officer: SVP & Chief Financial Officer 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Eli Casdin director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Partners Fo1-msv, Lp director C/O CASDIN PARTNERS GP, LLC, 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii Gp, Llc director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Partners Gp, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Capital, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii, L.p. director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Fenel M Eloi director C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452
Caligan Partners Lp 10 percent owner 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022
Frank Witney director 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Jeremy Steven Davis officer: SVP Chief Commercial Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Hanjoon Alex Kim officer: Chief Operating Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Michael Egholm director, officer: President & CEO 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110